Global Anti-Tumor Drugs Market Research Report 2024

Report ID: 1987615 | Published Date: Jan 2025 | No. of Page: 74 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Anti-Tumor Drugs Market Overview
    1.1 Product Overview and Scope of Anti-Tumor Drugs
    1.2 Anti-Tumor Drugs Segment by Type
        1.2.1 Global Anti-Tumor Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Surgical
        1.2.3 Chemotherapy
        1.2.4 Radiation
        1.2.5 Targeted
        1.2.6 Immunotherapy
    1.3 Anti-Tumor Drugs Segment by Application
        1.3.1 Global Anti-Tumor Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital Use
        1.3.3 Clinic Use
        1.3.4 Household
        1.3.5 Other
    1.4 Global Anti-Tumor Drugs Market Size Estimates and Forecasts
        1.4.1 Global Anti-Tumor Drugs Revenue 2017-2028
        1.4.2 Global Anti-Tumor Drugs Sales 2017-2028
        1.4.3 Anti-Tumor Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-Tumor Drugs Market Competition by Manufacturers
    2.1 Global Anti-Tumor Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Anti-Tumor Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Anti-Tumor Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Anti-Tumor Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Anti-Tumor Drugs Market Competitive Situation and Trends
        2.5.1 Anti-Tumor Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Anti-Tumor Drugs Players Market Share by Revenue
        2.5.3 Global Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Tumor Drugs Retrospective Market Scenario by Region
    3.1 Global Anti-Tumor Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Anti-Tumor Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Anti-Tumor Drugs Market Facts & Figures by Country
        3.3.1 North America Anti-Tumor Drugs Sales by Country
        3.3.2 North America Anti-Tumor Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Anti-Tumor Drugs Market Facts & Figures by Country
        3.4.1 Europe Anti-Tumor Drugs Sales by Country
        3.4.2 Europe Anti-Tumor Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Anti-Tumor Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Anti-Tumor Drugs Sales by Region
        3.5.2 Asia Pacific Anti-Tumor Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Anti-Tumor Drugs Market Facts & Figures by Country
        3.6.1 Latin America Anti-Tumor Drugs Sales by Country
        3.6.2 Latin America Anti-Tumor Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Anti-Tumor Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Anti-Tumor Drugs Sales by Country
        3.7.2 Middle East and Africa Anti-Tumor Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Anti-Tumor Drugs Historic Market Analysis by Type
    4.1 Global Anti-Tumor Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Anti-Tumor Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Anti-Tumor Drugs Price by Type (2017-2022)
5 Global Anti-Tumor Drugs Historic Market Analysis by Application
    5.1 Global Anti-Tumor Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Anti-Tumor Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Anti-Tumor Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Roche
        6.1.1 Roche Corporation Information
        6.1.2 Roche Description and Business Overview
        6.1.3 Roche Anti-Tumor Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Roche Anti-Tumor Drugs Product Portfolio
        6.1.5 Roche Recent Developments/Updates
    6.2 Novartis
        6.2.1 Novartis Corporation Information
        6.2.2 Novartis Description and Business Overview
        6.2.3 Novartis Anti-Tumor Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Novartis Anti-Tumor Drugs Product Portfolio
        6.2.5 Novartis Recent Developments/Updates
    6.3 Celgene
        6.3.1 Celgene Corporation Information
        6.3.2 Celgene Description and Business Overview
        6.3.3 Celgene Anti-Tumor Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Celgene Anti-Tumor Drugs Product Portfolio
        6.3.5 Celgene Recent Developments/Updates
7 Anti-Tumor Drugs Manufacturing Cost Analysis
    7.1 Anti-Tumor Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Anti-Tumor Drugs
    7.4 Anti-Tumor Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Anti-Tumor Drugs Distributors List
    8.3 Anti-Tumor Drugs Customers
9 Anti-Tumor Drugs Market Dynamics
    9.1 Anti-Tumor Drugs Industry Trends
    9.2 Anti-Tumor Drugs Market Drivers
    9.3 Anti-Tumor Drugs Market Challenges
    9.4 Anti-Tumor Drugs Market Restraints
10 Global Market Forecast
    10.1 Anti-Tumor Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Anti-Tumor Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Anti-Tumor Drugs by Type (2023-2028)
    10.2 Anti-Tumor Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Anti-Tumor Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Anti-Tumor Drugs by Application (2023-2028)
    10.3 Anti-Tumor Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Anti-Tumor Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Anti-Tumor Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Anti-Tumor Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Anti-Tumor Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Anti-Tumor Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Anti-Tumor Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Anti-Tumor Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Anti-Tumor Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Anti-Tumor Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Anti-Tumor Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Anti-Tumor Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Anti-Tumor Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Anti-Tumor Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Anti-Tumor Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Tumor Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Anti-Tumor Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Anti-Tumor Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Anti-Tumor Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Anti-Tumor Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Anti-Tumor Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Anti-Tumor Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Anti-Tumor Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Anti-Tumor Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Anti-Tumor Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Anti-Tumor Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Anti-Tumor Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Anti-Tumor Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Anti-Tumor Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Anti-Tumor Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Anti-Tumor Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Anti-Tumor Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Anti-Tumor Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Anti-Tumor Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Anti-Tumor Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Anti-Tumor Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Anti-Tumor Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Anti-Tumor Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Anti-Tumor Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Anti-Tumor Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Anti-Tumor Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Anti-Tumor Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Anti-Tumor Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Anti-Tumor Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Anti-Tumor Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Anti-Tumor Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Anti-Tumor Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Anti-Tumor Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Anti-Tumor Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Roche Corporation Information
    Table 50. Roche Description and Business Overview
    Table 51. Roche Anti-Tumor Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Roche Anti-Tumor Drugs Product
    Table 53. Roche Recent Developments/Updates
    Table 54. Novartis Corporation Information
    Table 55. Novartis Description and Business Overview
    Table 56. Novartis Anti-Tumor Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Novartis Anti-Tumor Drugs Product
    Table 58. Novartis Recent Developments/Updates
    Table 59. Celgene Corporation Information
    Table 60. Celgene Description and Business Overview
    Table 61. Celgene Anti-Tumor Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Celgene Anti-Tumor Drugs Product
    Table 63. Celgene Recent Developments/Updates
    Table 64. Production Base and Market Concentration Rate of Raw Material
    Table 65. Key Suppliers of Raw Materials
    Table 66. Anti-Tumor Drugs Distributors List
    Table 67. Anti-Tumor Drugs Customers List
    Table 68. Anti-Tumor Drugs Market Trends
    Table 69. Anti-Tumor Drugs Market Drivers
    Table 70. Anti-Tumor Drugs Market Challenges
    Table 71. Anti-Tumor Drugs Market Restraints
    Table 72. Global Anti-Tumor Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 73. Global Anti-Tumor Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 74. Global Anti-Tumor Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 75. Global Anti-Tumor Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 76. Global Anti-Tumor Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 77. Global Anti-Tumor Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 78. Global Anti-Tumor Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 79. Global Anti-Tumor Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 80. Global Anti-Tumor Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 81. Global Anti-Tumor Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 82. Global Anti-Tumor Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 83. Global Anti-Tumor Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anti-Tumor Drugs
    Figure 2. Global Anti-Tumor Drugs Market Share by Type in 2021 & 2028
    Figure 3. Surgical Product Picture
    Figure 4. Chemotherapy Product Picture
    Figure 5. Radiation Product Picture
    Figure 6. Targeted Product Picture
    Figure 7. Immunotherapy Product Picture
    Figure 8. Global Anti-Tumor Drugs Market Share by Application in 2021 & 2028
    Figure 9. Hospital Use
    Figure 10. Clinic Use
    Figure 11. Household
    Figure 12. Other
    Figure 13. Global Anti-Tumor Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Anti-Tumor Drugs Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Anti-Tumor Drugs Sales (2017-2028) & (K Units)
    Figure 16. Anti-Tumor Drugs Sales Share by Manufacturers in 2021
    Figure 17. Global Anti-Tumor Drugs Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Anti-Tumor Drugs Players: Market Share by Revenue in 2021
    Figure 19. Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Anti-Tumor Drugs Sales Market Share by Region (2017-2022)
    Figure 21. Global Anti-Tumor Drugs Sales Market Share by Region in 2021
    Figure 22. Global Anti-Tumor Drugs Revenue Market Share by Region (2017-2022)
    Figure 23. Global Anti-Tumor Drugs Revenue Market Share by Region in 2021
    Figure 24. U.S. Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. U.A.E Anti-Tumor Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Anti-Tumor Drugs by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Anti-Tumor Drugs
    Figure 50. Manufacturing Process Analysis of Anti-Tumor Drugs
    Figure 51. Anti-Tumor Drugs Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Celgene
Frequently Asked Questions
Anti-Tumor Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Anti-Tumor Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Anti-Tumor Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Application Server

Application Server market is segmented by players, region (country), by Type and by Application.  ... Read More